NCT00660712已完成不适用
Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,018
- 试验地点
- 1
- 主要终点
- Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
研究概览
简要总结
A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients previously or currently diagnosed with bipolar disorder
- •Patients (or any of their relatives) who give a written informed consent.
排除标准
- •Patients who were previously included in this study.
结局指标
主要结局
Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
次要结局
- Identification of treatment modalities selected according to the disease phase
- Identification of the number of first degree relatives diagnosed with bipolar disorder
- Evaluation of the relationship between patient and disease characteristics
- Evaluation of co-morbid psychiatric diseases
- Evaluation of the time period that elapsed since the diagnosis of bipolar disorder
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Clinical Pulmonary EmbolismAcute Pulmonary EmbolismNCT05469724Assiut University100
招募中
不适用
Venetoclax RegistryAcute Myeloid LeukemiaNCT03662724Hannover Medical School100
撤回
不适用
Characteristics of Patients With COVID-19 in Meta State, ColombiaCOVIDSARS-CoV 2SARS PneumoniaSARS (Disease)SARS (Severe Acute Respiratory Syndrome)NCT04456426Hospital Departamental de Villavicencio
已完成
不适用
Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination TherapyBreast CancerNCT04394247Pfizer242
已完成
不适用
A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on PanobinostatMultiple MyelomaNCT04150289pharmaand GmbH248